{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:48:10Z","timestamp":1774468090713,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK128597"],"award-info":[{"award-number":["R01DK128597"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11095-025-03946-9","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:49:52Z","timestamp":1762447792000},"page":"2235-2245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and In Vitro Evaluation of Gambogic Acid-Conjugated Stearic Acid Solid Lipid Nanoparticles for Transferrin Receptor-Mediated Drug Delivery"],"prefix":"10.1007","volume":"42","author":[{"given":"Raghu","family":"Ganugula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirivinti Hayagreeva","family":"Dinakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Kurse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. N. V. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-3153","authenticated-orcid":false,"given":"Meenakshi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"2","key":"3946_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1021\/acs.chemmater.2c03003","volume":"35","author":"J Gao","year":"2023","unstructured":"Gao J, Karp JM, Langer R, Joshi N. The future of drug delivery. Chem Mater. 2023;35(2):359\u201363. https:\/\/doi.org\/10.1021\/acs.chemmater.2c03003.","journal-title":"Chem Mater"},{"issue":"3","key":"3946_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1021\/jacs.5b09974","volume":"138","author":"MW Tibbitt","year":"2016","unstructured":"Tibbitt MW, Dahlman JE, Langer R. Emerging frontiers in drug delivery. J Am Chem Soc. 2016;138(3):704\u201317. https:\/\/doi.org\/10.1021\/jacs.5b09974.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"3946_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5530\/ijpi.20251676","volume":"15","author":"S Makkad","year":"2024","unstructured":"Makkad S, Sheikh M, Shende S, Jirvankar P. Pharmaceutical excipients: functions, selection criteria, and emerging trends. Int J Pharm Investig. 2025;15(2):361\u201376. https:\/\/doi.org\/10.5530\/ijpi.20251676.","journal-title":"Int J Pharm Investig"},{"issue":"6","key":"3946_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1208\/s12248-015-9814-9","volume":"17","author":"H Wen","year":"2015","unstructured":"Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J. 2015;17(6):1327\u201340. https:\/\/doi.org\/10.1208\/s12248-015-9814-9.","journal-title":"AAPS J"},{"issue":"9","key":"3946_CR5","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.drudis.2020.07.005","volume":"25","author":"L Zhao","year":"2020","unstructured":"Zhao L, Ciallella HL, Aleksunes LM, Zhu H. Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling. Drug Discov Today. 2020;25(9):1624\u201338.\u00a0https:\/\/doi.org\/10.1016\/j.drudis.2020.07.005.","journal-title":"Drug Discov Today"},{"issue":"9","key":"3946_CR6","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, Such GK. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124(9):5505\u2013616.\u00a0https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705.","journal-title":"Chem Rev"},{"issue":"3","key":"3946_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1021\/cr300047q","volume":"113","author":"VR Devadasu","year":"2013","unstructured":"Devadasu VR, Bhardwaj V, Kumar MNVR. Can controversial nanotechnology promise drug delivery? Chem Rev. 2013;113(3):1686\u2013735.\u00a0https:\/\/doi.org\/10.1021\/cr300047q.","journal-title":"Chem Rev"},{"issue":"2","key":"3946_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103344","volume":"28","author":"S Stegemann","year":"2023","unstructured":"Stegemann S, Moreton C, Svanback S, Box K, Motte G, Paudel A. Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five. Drug Discov Today. 2023;28(2):103344.\u00a0https:\/\/doi.org\/10.1016\/j.drudis.2022.103344.","journal-title":"Drug Discov Today"},{"key":"3946_CR9","unstructured":"Sperry M, Ingber PDE. Drug repurposing strategies, challenges and successes. Drug Discovery. 2024. https:\/\/www.technologynetworks.com\/drug-discovery\/articles\/drug-repurposing-strategies-challenges-and-successes-384263."},{"issue":"2","key":"3946_CR10","first-page":"30","volume":"19","author":"C Dubin","year":"2019","unstructured":"Dubin C. Improving bioavailability & solubility: chemical & physical modification vs. formulation development. Drug Development and Delivery. 2019;19(2):30\u20136.\u00a0https:\/\/drug-dev.com\/special-feature-improving-bioavailability-solubility-chemical-physical-modification-vs-formulation-development\/.","journal-title":"Drug Development and Delivery"},{"issue":"4","key":"3946_CR11","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1021\/mp500737y","volume":"12","author":"J-H Kim","year":"2015","unstructured":"Kim J-H, Kim Y, Bae KH, Park TG, Lee JH, Park K. Tumor-targeted delivery of Paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles. Mol Pharm. 2015;12(4):1230\u201341.\u00a0https:\/\/doi.org\/10.1021\/mp500737y.","journal-title":"Mol Pharm"},{"issue":"2","key":"3946_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/pim.70002","volume":"47","author":"M Heidari-Kharaji","year":"2025","unstructured":"Heidari-Kharaji M, Rodrigues P, Petersen C. Solid lipid nanoparticles encapsulated with Paromomycin: an effective oral formulation against Leishmania major in mouse model. Parasite Immunol. 2025;47(2):e70002.\u00a0https:\/\/doi.org\/10.1111\/pim.70002.","journal-title":"Parasite Immunol"},{"key":"3946_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.addr.2021.03.004","volume":"173","author":"SH El Moukhtari","year":"2021","unstructured":"El Moukhtari SH, Rodriguez-Nogales C, Blanco-Prieto MJ. Oral lipid nanomedicines: current status and future perspectives in cancer treatment. Adv Drug Deliv Rev. 2021;173:238\u201351.\u00a0https:\/\/doi.org\/10.1016\/j.addr.2021.03.004.","journal-title":"Adv Drug Deliv Rev"},{"key":"3946_CR14","doi-asserted-by":"publisher","unstructured":"Shailaja Kasibhatla KAJ, Sergei Maliartchouk, Wang JY, English NM, JDrewe J, Qiu L, Archer SP, Ponce AE, Sirisoma N, Jiang S, Zhang H-Z, Gehlsen KR, Cai SX, Green DR, Tseng B. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Biol Sci. 2005;102(34):12095\u201312100. https:\/\/doi.org\/10.1073\/pnas.0406731102.","DOI":"10.1073\/pnas.0406731102"},{"key":"3946_CR15","doi-asserted-by":"publisher","first-page":"29501","DOI":"10.1038\/srep29501","volume":"6","author":"P Saini","year":"2016","unstructured":"Saini P, Ganugula R, Arora M, Kumar MN. The next generation non-competitive active polyester nanosystems for transferrin receptor-mediated peroral transport utilizing gambogic acid as a ligand. Sci Rep. 2016;6:29501.\u00a0https:\/\/doi.org\/10.1038\/srep29501.","journal-title":"Sci Rep"},{"issue":"8","key":"3946_CR16","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1021\/acsabm.9b00419","volume":"2","author":"M Arora","year":"2019","unstructured":"Arora M, Ganugula R, Kumar N, Kaur G, Pellois JP, Garg P, Kumar M. Next-generation noncompetitive nanosystems based on Gambogic acid: in silico identification of transferrin receptor binding sites, regulatory shelf stability, and their preliminary safety in healthy rodents. ACS Appl Bio Mater. 2019;2(8):3540\u201350.\u00a0https:\/\/doi.org\/10.1021\/acsabm.9b00419.","journal-title":"ACS Appl Bio Mater"},{"issue":"34","key":"3946_CR17","doi-asserted-by":"publisher","first-page":"12095","DOI":"10.1073\/pnas.0406731102","volume":"102","author":"S Kasibhatla","year":"2005","unstructured":"Huang G-M, Sun Y, Ge X, Wan X,Li C-B. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways. World J Gasttroentrol. 2015;21:6194\u20136205.\u00a0https:\/\/doi.org\/10.3748\/wjg.v21.i20.6194.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"3946_CR18","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/bc300561e","volume":"23","author":"AN Lowell","year":"2012","unstructured":"Lowell AN, Qiao H, Liu T, Ishikawa T, Zhang H, Oriana S, Wang M, Ricciotti E, FitzGerald GA, Zhou R, Yamakoshi Y. Functionalized low-density lipoprotein nanoparticles for in vivo enhancement of atherosclerosis on magnetic resonance images. Bioconjug Chem. 2012;23(11):2313\u20139.\u00a0https:\/\/doi.org\/10.1021\/bc300561e.","journal-title":"Bioconjug Chem"},{"issue":"5","key":"3946_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1021\/acs.molpharmaceut.6b01027","volume":"14","author":"D Irby","year":"2017","unstructured":"Irby D, Du C, Li F. Lipid-drug conjugate for enhancing drug delivery. Mol Pharm. 2017;14(5):1325\u201338.\u00a0https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b01027.","journal-title":"Mol Pharm"},{"key":"3946_CR20","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/IJN.S198353","volume":"14","author":"A Mukherjee","year":"2019","unstructured":"Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomed. 2019;14:1937\u201352.\u00a0https:\/\/doi.org\/10.2147\/ijn.s198353.","journal-title":"Int J Nanomed"},{"key":"3946_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fhfh.2022.100054","author":"T Dissanayake","year":"2022","unstructured":"Dissanayake T, Sun X, Abbey L, Bandara N. Recent advances in lipid-protein conjugate-based delivery systems in nutraceutical, drug, and gene delivery. Food Hydrocolloids for Health. 2022; 4:100054.\u00a0https:\/\/doi.org\/10.1016\/j.fhfh.2022.100054.","journal-title":"Food Hydrocolloids for Health"},{"key":"3946_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jconrel.2021.12.027","volume":"344","author":"H Parhiz","year":"2022","unstructured":"Parhiz H, Brenner JS, Patel PN, Papp TE, Shahnawaz H, Li Q, Shi R, Zamora ME, Yadegari A, Marcos-Contreras OA, Natesan A, Pardi N, Shuvaev VV, Kiseleva R, Myerson JW, Uhler T, Riley RS, Han X, Mitchell MJ, Lam K, Heyes J, Weissman D, Muzykantov VR. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE). J Control Release. 2022;344:50\u201361.\u00a0https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.027.","journal-title":"J Control Release"},{"key":"3946_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2020.110129","author":"M Tavares Luiz","year":"2021","unstructured":"Tavares Luiz M, Delello Di Filippo L, Carolina Alves R, Sousa Ara\u00fajo VH, Lobato Duarte J, Maldonado Marchetti J, Chorilli M. The use of TPGS in drug delivery systems to overcome biological barriers. Eur Polym J.2021;142.\u00a0https:\/\/ui.adsabs.harvard.edu\/link_gateway\/2021EurPJ.14210129T\/doi:10.1016\/j.eurpolymj.2020.110129.","journal-title":"Eur Polym J"},{"issue":"1","key":"3946_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijpharm.2016.07.049","volume":"511","author":"H Li","year":"2016","unstructured":"Li H, Chen M, Su Z, Sun M, Ping Q. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Int J Pharm. 2016;511(1):524\u201337.\u00a0https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.049.","journal-title":"Int J Pharm"},{"key":"3946_CR25","doi-asserted-by":"publisher","unstructured":"Wolfgang Mehnert KM. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2001):165\u2013196. https:\/\/doi.org\/10.1016\/s0169-409x(01)00105-3.","DOI":"10.1016\/s0169-409x(01)00105-3"},{"issue":"6","key":"3946_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.addr.2007.09.006","volume":"60","author":"V Jannin","year":"2008","unstructured":"Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):734\u201346.\u00a0https:\/\/doi.org\/10.1016\/j.addr.2007.09.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"3946_CR27","doi-asserted-by":"publisher","unstructured":"Mileda N, SC, LD, * AR, MR, Carri\u00e8rea F, AdC, CC, RV. Digestive lipases: From three-dimensional structure to physiology. Biochimie. 2000;82(2000):973\u2013986. https:\/\/doi.org\/10.1016\/s0300-9084(00)01179-2.","DOI":"10.1016\/s0300-9084(00)01179-2"},{"issue":"1","key":"3946_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/026520499289310","volume":"16","author":"C Freitas","year":"1999","unstructured":"Freitas C. Stability determination of solid lipid nanoparticles (SLN TM) in aqueous dispersion after addition of electrolyte. J Microencapsul. 1999;16(1):59\u201371.\u00a0https:\/\/doi.org\/10.1080\/026520499289310.","journal-title":"J Microencapsul"},{"key":"3946_CR29","doi-asserted-by":"publisher","first-page":"106556","DOI":"10.1016\/j.ejps.2023.106556","volume":"189","author":"R Holm","year":"2023","unstructured":"Holm R, Kuentz M, Ilie-Spiridon AR, Griffin BT. Lipid based formulations as supersaturating oral delivery systems: from current to future industrial applications. Eur J Pharm Sci. 2023;189:106556.\u00a0https:\/\/doi.org\/10.1016\/j.ejps.2023.106556.","journal-title":"Eur J Pharm Sci."},{"issue":"2","key":"3946_CR30","doi-asserted-by":"publisher","first-page":"G261","DOI":"10.1152\/ajpgi.00052.2005","volume":"289","author":"DD Burton","year":"2005","unstructured":"Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O\u2019Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005;289(2):G261\u2013266.\u00a0https:\/\/doi.org\/10.1152\/ajpgi.00052.2005.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3946_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1142001","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang J, Liang Y, Zhou L. Natural products for kidney disease treatment: focus on targeting mitochondrial dysfunction. Front Pharmacol. 2023;14:1142001. https:\/\/doi.org\/10.3389\/fphar.2023.1142001.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3946_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31373\/ejtcm\/137918","volume":"5","author":"M Kotewicz","year":"2022","unstructured":"Kotewicz M, Lewko B. Urolithins and their possible implications for diabetic kidney. European Journal of Translational and Clinical Medicine. 2022;5(1):53\u201363.\u00a0https:\/\/doi.org\/10.31373\/ejtcm\/137918.","journal-title":"European Journal of Translational and Clinical Medicine"},{"key":"3946_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106939","volume":"203","author":"EA Elmorsy","year":"2024","unstructured":"Elmorsy EA, Saber S, Hamad RS, Abdel-Reheim MA, El-Kott AF, AlShehri MA, Morsy K, Salama SA, Youssef ME. Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies. Eur J Pharm Sci. 2024;203:106939. https:\/\/doi.org\/10.1016\/j.ejps.2024.106939.","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"3946_CR34","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1021\/acs.chemrestox.9b00204","volume":"32","author":"L Qi","year":"2019","unstructured":"Qi L, Luo Q, Zhang Y, Jia F, Zhao Y, Wang F. Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol. 2019;32(8):1469\u201386. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00204.","journal-title":"Chem Res Toxicol"},{"key":"3946_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2024.1436896","volume":"4","author":"R Lyrio","year":"2024","unstructured":"Lyrio R, Rocha BRA, Correa A, Mascarenhas MGS, Santos FL, Maia RDH, Segundo LB, de Almeida PAA, Moreira CMO, Sassi RH. Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches. Front Nephrol. 2024;4:1436896. https:\/\/doi.org\/10.3389\/fneph.2024.1436896.","journal-title":"Front Nephrol"},{"issue":"5","key":"3946_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/ckj\/sfab292","volume":"15","author":"P Braet","year":"2022","unstructured":"Braet P, Sarto GVR, Pirovano M, Sprangers B, Cosmai L. Treatment of acute kidney injury in cancer patients. Clin Kidney J. 2022;15(5):873\u201384. https:\/\/doi.org\/10.1093\/ckj\/sfab292.","journal-title":"Clin Kidney J"},{"key":"3946_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.lfs.2015.12.003","volume":"144","author":"H Zhao","year":"2016","unstructured":"Zhao H, Zheng Q, Hu X, Shen H, Li F. Betulin attenuates kidney injury in septic rats through inhibiting TLR4\/NF-kappaB signaling pathway. Life Sci. 2016;144:185\u201393. https:\/\/doi.org\/10.1016\/j.lfs.2015.12.003.","journal-title":"Life Sci"},{"issue":"1","key":"3946_CR38","doi-asserted-by":"publisher","first-page":"2313176","DOI":"10.1080\/0886022X.2024.2313176","volume":"46","author":"YM Xia","year":"2024","unstructured":"Xia YM, Guan YQ, Liang JF, Wu WD. Tak-242 improves sepsis-associated acute kidney injury in rats by inhibiting the TLR4\/NF-kappaB signaling pathway. Ren Fail. 2024;46(1):2313176. https:\/\/doi.org\/10.1080\/0886022X.2024.2313176.","journal-title":"Ren Fail"},{"issue":"3","key":"3946_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06441","volume":"7","author":"R Habib","year":"2021","unstructured":"Habib R. Multifaceted roles of toll-like receptors in acute kidney injury. Heliyon. 2021;7(3):e06441. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06441.","journal-title":"Heliyon"},{"key":"3946_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114334","volume":"200","author":"W Pula","year":"2024","unstructured":"Pula W, Ganugula R, Esposito E, Ravi Kumar MNV, Arora M. Engineered urolithin A-laden functional polymer-lipid hybrid nanoparticles prevent cisplatin-induced proximal tubular injury in vitro. Eur J Pharm Biopharm. 2024;200:114334. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114334.","journal-title":"Eur J Pharm Biopharm"},{"key":"3946_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2021.02.009","volume":"332","author":"D Zou","year":"2021","unstructured":"Zou D, Arora M, Ganugula R, Kumar M, Scott EM, Shah D, Kumar M. Nanoparticles that do not compete with endogenous ligands - Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans. J Control Release. 2021;332:64\u201373.\u00a0https:\/\/doi.org\/10.1016\/j.jconrel.2021.02.009.","journal-title":"J Control Release"},{"issue":"5","key":"3946_CR42","doi-asserted-by":"publisher","first-page":"F1255","DOI":"10.1152\/ajprenal.00346.2019","volume":"317","author":"D Zou","year":"2019","unstructured":"Zou D, Ganugula R, Arora M, Nabity MB, Sheikh-Hamad D, Kumar M. Oral delivery of nanoparticle urolithin A normalizes cellular stress and improves survival in mouse model of cisplatin-induced AKI. Am J Physiol Renal Physiol. 2019;317(5):F1255\u201364. https:\/\/doi.org\/10.1152\/ajprenal.00346.2019.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"3946_CR43","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1681\/ASN.2007090982","volume":"19","author":"B Zhang","year":"2008","unstructured":"Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol. 2008;19(5):923\u201332.\u00a0https:\/\/doi.org\/10.1681\/asn.2007090982.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3946_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/acel.12322","volume":"14","author":"S Gargiulo","year":"2015","unstructured":"Gargiulo S, Gamba P, Testa G, Rossin D, Biasi F, Poli G, Leonarduzzi G. Relation between TLR4\/NF-kappaB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability. Aging Cell. 2015;14(4):569\u201381. https:\/\/doi.org\/10.1111\/acel.12322.","journal-title":"Aging Cell"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03946-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:50:56Z","timestamp":1768927856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03946-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3946"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03946-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}